Latest / Stock Movers / Nvidia Up, Campbell's Gains, Eli Lilly Rises as 30% Weight Loss Sets High Bar for Obesity Drug Race
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio News, The Stock Movers Report,
- 0:10Speaker 1: your roundup of companies making moves in the stock market,
- 0:13Speaker 1: harnessing the power of Bloomberg data.
- 0:16Speaker 2: Let's take a look at some of the stocks on
- 0:17Speaker 2: the move today. We do that with Tatiana Daria, strategist
- 0:20Speaker 2: from Markets Live of Bloomberg New Statuents here in our studio, Tatana,
- 0:23Speaker 2: what are you looking at?
- 0:24Speaker 3: Let me start with Nvidia up about one percent, was
- 0:27Speaker 3: leading against in the SMP five hundred earlier. It has
- 0:31Speaker 3: a sort of a lot of things going on this morning.
- 0:34Speaker 3: It's signed a multi year pact with sk Heinez to
- 0:37Speaker 3: design the next generation of AI memory chips, which we
- 0:40Speaker 3: all know are in very high demand. Separately, it's also
- 0:43Speaker 3: agreed to deepen its alliance with Hyundai Motor Group to
- 0:46Speaker 3: turn so called physical AI and robotics into real industrial products.
- 0:50Speaker 3: We know that's been sort of a key focus of
- 0:53Speaker 3: jensen Huang and the next next big addressable market for chips.
- 0:58Speaker 3: So the roadmap to be moving robotics from the research
- 1:02Speaker 3: labs to actual factory floors, and not least because jensen
- 1:06Speaker 3: Huang also told reporters that the global tech sell off
- 1:09Speaker 3: is a buying opportunity. Maybe that's why we're seeing so
- 1:12Speaker 3: much green on the screen here saying that the building
- 1:15Speaker 3: of the AI build out, the AI buildout has just begun.
- 1:20Speaker 3: So it looks like some of those traders have been
- 1:24Speaker 3: listening to what mister Honk has been saying. It is
- 1:27Speaker 3: all all right, good stuff. Next on your list, Well,
- 1:31Speaker 3: I'll pick up on Campbell soup, New Jersey based Campbell
- 1:34Speaker 3: john to just google it. It's an hour's drive from
- 1:37Speaker 3: my house. Maybe I should pay a visit to understand
- 1:39Speaker 3: what's going on this shoe factory to the zup factory. Well,
- 1:44Speaker 3: the stock is a slightly lower, was up higher, so
- 1:47Speaker 3: it has been swinging this morning after a pretty mixed
- 1:50Speaker 3: earnings set. While net sales slightly lower than expectations, adjusted
- 1:54Speaker 3: GPS beat estimates, so that helped the stock earlier. But
- 1:58Speaker 3: after the call things have to and around here a
- 2:01Speaker 3: little bit. Analysted Piper Sandler saying that the retraded fullier
- 2:06Speaker 3: guidance looks achievable, but that margins are still pressured and
- 2:10Speaker 3: they're down a year over year. The company also eliminated
- 2:14Speaker 3: and share repurchases, no plans to boost the dividend. These
- 2:18Speaker 3: are things that investors are not liking. And I know
- 2:21Speaker 3: it's leaving the S and P five hundred, not exactly
- 2:23Speaker 3: on the day, but it is leaving. And I think
- 2:27Speaker 3: Marvell is a company that it will replace it that
- 2:30Speaker 3: attel class. Where we are right.
- 2:33Speaker 2: Now, Manhattan clam chatter, that's my go to all right,
- 2:36Speaker 2: how about Eli Lily.
- 2:38Speaker 3: Ali Lily, Well, the race for abusity drugs just got
- 2:41Speaker 3: tougher after the latest American Diabetes Association meeting where Eli
- 2:46Speaker 3: Lily presented data for the next generation weight loss drug
- 2:49Speaker 3: that can help patients lose thirty percent of their body
- 2:52Speaker 3: weight over about two years. And that's after pears including
- 2:57Speaker 3: Roach had a tougher time. And this meaning what they're
- 3:00Speaker 3: drugs less competitive on weight loss and what higher side effects.
- 3:05Speaker 3: And this comes at a time when those pharma companies
- 3:07Speaker 3: are trying to challenge the dominance of Eli Lilly and
- 3:10Speaker 3: Nova Ordix in this space. And apparently the narrative is
- 3:13Speaker 3: now moving from just an efficity pill to something more
- 3:17Speaker 3: holistic of lifestyle, you know, better results, more convenient, lower
- 3:21Speaker 3: side effects. And Eli Lilly executives made sure to you
- 3:27Speaker 3: convey the message that they're also working on that in
- 3:30Speaker 3: that the years ahead, they're going to move from a
- 3:32Speaker 3: one size it's all approach to something more tailored to
- 3:35Speaker 3: customer's needs.
- 3:38Speaker 1: The Stock Movers Report from Bloomberg Radio. Check back with
- 3:42Speaker 1: us throughout the day for the latest roundup of companies
- 3:44Speaker 1: making news on Wall Street and for the latest market
- 3:48Speaker 1: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 3:52Speaker 1: Bloomberg dot com, and on Applecarplay and Android Auto with
- 3:56Speaker 1: the Bloomberg Business app.